Semnur Pharmaceuticals, Inc.
SMNR
$9.00
-$10.00-52.63%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 55.00K | 7.00K | 12.00K | 12.00K | 15.00K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | 2.00K | 2.00K | 11.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 8.34M | 6.82M | 5.98M | 5.98M | -- |
| Total Current Assets | 8.39M | 6.82M | 6.00M | 6.00M | 26.00K |
|
|
|||||
| Total Current Assets | 8.39M | 6.82M | 6.00M | 6.00M | 26.00K |
| Net Property, Plant & Equipment | 689.00K | 689.00K | 689.00K | 689.00K | 689.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 9.08M | 7.51M | 6.68M | 6.68M | 715.00K |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 1.33M | 184.00K | 35.00K | 35.00K | 67.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 23.00K | 23.00K | -- | -- | 23.00K |
| Total Other Current Liabilities | 23.00K | 23.00K | -- | -- | 23.00K |
| Total Current Liabilities | 1.36M | 207.00K | 35.00K | 35.00K | 90.00K |
|
|
|||||
| Total Current Liabilities | 1.36M | 207.00K | 35.00K | 35.00K | 90.00K |
| Long-Term Debt | 52.17M | 50.76M | 49.43M | 49.43M | 41.34M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 53.53M | 50.96M | 49.47M | 49.47M | 41.43M |
|
|
|||||
| Common Stock & APIC | 72.60M | 72.60M | 72.60M | 72.60M | 72.60M |
| Retained Earnings | -117.05M | -116.05M | -115.38M | -115.38M | -113.31M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -44.45M | -43.45M | -42.78M | -42.78M | -40.71M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -44.45M | -43.45M | -42.78M | -42.78M | -40.71M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -44.45M | -43.45M | -42.78M | -42.78M | -40.71M |
|
|
|||||